Allianz Asset Management GmbH grew its position in Medical Properties Trust, Inc. (NYSE:MPW) by 4.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 579,254 shares of the real estate investment trust’s stock after buying an additional 23,561 shares during the period. Allianz Asset Management GmbH owned 0.16% of Medical Properties Trust worth $7,531,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in MPW. Ceredex Value Advisors LLC bought a new stake in shares of Medical Properties Trust in the 1st quarter valued at about $66,789,000. Earnest Partners LLC boosted its holdings in shares of Medical Properties Trust by 24.8% in the 4th quarter. Earnest Partners LLC now owns 4,109,100 shares of the real estate investment trust’s stock valued at $56,623,000 after buying an additional 816,225 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Medical Properties Trust by 1.6% in the 1st quarter. BlackRock Inc. now owns 40,232,523 shares of the real estate investment trust’s stock valued at $523,023,000 after buying an additional 632,842 shares in the last quarter. Raymond James & Associates boosted its holdings in shares of Medical Properties Trust by 63.7% in the 4th quarter. Raymond James & Associates now owns 1,607,527 shares of the real estate investment trust’s stock valued at $22,152,000 after buying an additional 625,766 shares in the last quarter. Finally, LSV Asset Management boosted its holdings in shares of Medical Properties Trust by 4.8% in the 1st quarter. LSV Asset Management now owns 9,207,800 shares of the real estate investment trust’s stock valued at $119,701,000 after buying an additional 419,700 shares in the last quarter. Institutional investors and hedge funds own 78.39% of the company’s stock.
In other news, Chairman Edward K. Aldag, Jr. sold 116,216 shares of the stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $12.56, for a total value of $1,459,672.96. Following the completion of the transaction, the chairman now directly owns 1,759,620 shares of the company’s stock, valued at approximately $22,100,827.20. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.83% of the company’s stock.
MPW stock opened at $14.06 on Thursday. Medical Properties Trust, Inc. has a 52 week low of $11.82 and a 52 week high of $14.19. The company has a quick ratio of 2.04, a current ratio of 2.04 and a debt-to-equity ratio of 1.27. The company has a market capitalization of $5.08 billion, a P/E ratio of 10.41, a P/E/G ratio of 2.60 and a beta of 0.73.
Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, May 3rd. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.36 by ($0.11). Medical Properties Trust had a return on equity of 8.14% and a net margin of 41.47%. The company had revenue of $205.05 million during the quarter, compared to analyst estimates of $204.70 million. During the same period in the previous year, the company posted $0.33 earnings per share. The company’s quarterly revenue was up 31.1% on a year-over-year basis. equities research analysts forecast that Medical Properties Trust, Inc. will post 1.42 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, July 12th. Stockholders of record on Thursday, June 14th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, June 13th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 7.11%. Medical Properties Trust’s payout ratio is presently 74.07%.
MPW has been the subject of a number of recent analyst reports. Deutsche Bank lowered their target price on shares of Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating for the company in a research note on Monday, March 19th. ValuEngine cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Zacks Investment Research cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, April 18th. Finally, Wells Fargo & Co lifted their target price on shares of Medical Properties Trust from $11.50 to $13.00 and gave the stock an “underperform” rating in a research note on Thursday, May 31st. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $14.15.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.